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The worldwide development of innovative 
products increasingly includes incorporat-
ing engineered nanomaterials (ENMs). It is 
likely that ENM use will become ever more 
common place in the future and provide many 
benefits, although harm from inadvertent 
human exposures may also increase. Some 
challenges in evaluation of ENM safety need 
to be addressed, especially considering that 
the pace of ENM development is exceeding 
the industry’s ability to sufficiently conduct 
animal safety testing (Maynard et al. 2006; 
Nel et al. 2006; Oberdörster et al. 2005). To 
address this issue, one of the goals in the field 
of nanotoxicology (or nanosafety) is develop-
ment of in vitro assays that are highly pre-
dictive of in vivo outcomes in order to triage 
those ENMs that should proceed to in vivo 
testing (Meng et al. 2009; Oberdörster et al. 
2005). Unfortunately, the presence of con-
flicting interlaboratory data on the relative 
hazard of individual ENMs is a concern for 
moving the reliability of in vitro testing for-
ward. Therefore, the National Institute of 
Environmental Health Sciences (NIEHS) 
developed a consortium program of experts in 
the field of pulmonary toxicology to conduct 
coordinated in vitro and in vivo assays with 
selected well-characterized ENMs. There are 
a number of potential causes of variability, 
including sources of ENM, ENM suspension 
protocols, selection of target cells, end points 
selected to evaluate ENM bioactivity, and 
details of cell culture and end point assays.
All consortium program participants 
(CPPs) received characterized ENMs for use in 
this study, including metal oxide nanospheres 
[rutile/anatase titanium dioxide (TiO2-P25), 
TiO2 anatase (TiO2-A), and zinc oxide (ZnO)] 
and high-aspect-ratio materials [multiwalled 
carbon nanotubes (MWCNTs) and TiO2 
nanobelts (TiO2-NBs)]. Furthermore, the 
CPPs tested three forms of MWCNT [original 
(O-MWCNT), purified (P-MWCNT) and 
functionalized (carboxylated) (F-MWCNT)]. 
The consortium chose cell lines for the assays 
based on respiratory tract exposure, thus, the 
cell types most likely to interact with ENM 
after deposition. As such, the cell lines included 
RLE-6TN (rat type II alveolar epithelial cell 
line), BEAS-2B (human bronchial epithelial 
cell line), and THP-1 (human monocyte/ 
macrophage cell line) (Dostert et al. 2008; 
Driscoll et al. 1995; Xia et al. 2008b). The con-
sortium developed ENM suspension protocols 
(in cell culture media) that were sufficiently 
reproducible among laboratories (Ji et al. 2010; 
Porter et al. 2008; Sager et al. 2007). The cell 
assays included traditional cytotoxicity testing 
(Xia et al. 2008b) and evaluation of the Nod-
like receptor protein 3 (NLRP3) inflamma-
some activation with THP-1 cells (Hamilton 
et al. 2009). The consortium chose the 
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Background: Differences in interlaboratory research protocols contribute to the conflicting data in 
the literature regarding engineered nanomaterial (ENM) bioactivity.
oBjectives: Grantees of a National Institute of Health Sciences (NIEHS)-funded consortium 
program performed two phases of in vitro testing with selected ENMs in an effort to identify and 
minimize sources of variability.
Methods: Consortium program participants (CPPs) conducted ENM bioactivity evaluations on 
zinc oxide (ZnO), three forms of titanium dioxide (TiO2), and three forms of multiwalled carbon 
nanotubes (MWCNTs). In addition, CPPs performed bioassays using three mammalian cell lines 
(BEAS-2B, RLE-6TN, and THP-1) selected in order to cover two different species (rat and human), 
two different lung epithelial cells (alveolar type II and bronchial epithelial cells), and two different 
cell types (epithelial cells and macrophages). CPPs also measured cytotoxicity in all cell types while 
measuring inflammasome activation [interleukin-1β (IL-1β) release] using only THP-1 cells.
results: The overall in vitro toxicity profiles of ENM were as follows: ZnO was cytotoxic to all 
cell types at ≥ 50 µg/mL, but did not induce IL-1β. TiO2 was not cytotoxic except for the nanobelt 
form, which was cytotoxic and induced significant IL-1β production in THP-1 cells. MWCNTs 
did not produce cytotoxicity, but stimulated lower levels of IL-1β production in THP-1 cells, with 
the original MWCNT producing the most IL-1β.
conclusions: The results provide justification for the inclusion of mechanism-linked bioactivity 
assays along with traditional cytotoxicity assays for in vitro screening. In addition, the results sug-
gest that conducting studies with multiple relevant cell types to avoid false-negative outcomes is 
critical for accurate evaluation of ENM bioactivity.
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inflammasome assay on the basis of evidence 
that a number of particles such as crystalline 
silica, asbestos, uric acid crystals, and cholesterol 
crystals activate the NLRP3 inflammasome, 
causing the release of interleukin (IL)-1β and 
IL-18 that have been linked to lung pathology 
(Cassel et al. 2008; Dostert et al. 2008; Franchi 
et al. 2009; Tschopp and Schroder 2010). For 
example, one of the CPP laboratories recently 
showed that TiO2-NBs stimulate the NLRP3 
inflammasome in primary murine macrophages 
(Hamilton et al. 2009). Here we describe the 
outcomes of the consortium’s in vitro studies, 
and Bonner et al. (2013) describe the in vivo 
studies conducted in rodents using the same 
well-characterized ENMs.
In the present study, the CPPs identified 
and minimized critical aspects of current ENM 
testing protocols that will potentially decrease 
the variability in reported outcomes from the 
various laboratories engaged in the field. In 
addition, the results of this study provide new 
information on the relative in vitro bioactiv-
ity of a large group of diverse ENMs that can 
be used to inform future strate gies for in vitro 
 testing and for predicting in vivo outcomes.
Materials and Methods
ENMs and reagents. The CPPs obtained 
ZnO from Meliorum Technologies Inc. 
(Rochester, NY). TiO2-P25 (81% anatase 
and 19% rutile) was purchased from Evonik 
(Parsippany, NJ); TiO2-A was provided by 
P. Biswas (Washington University, St. Louis, 
MO); and the CPPs prepared the TiO2-NBs 
as previously described (Hamilton et al. 
2009). The CPPs obtained the O-MWCNT 
stock in powder form from Cheap Tubes Inc. 
(Brattleboro, VT); obtained the P-MWCNT 
by treating O-MWCNT with dilute acids, 
chelating agents, and mild conditions to mini-
mize oxidized or damaged tubes; and created 
F-MWCNT through further acid treatment 
of P-MWCNT, which introduced carboxyl 
groups on 5.27% of the carbon backbone (on 
a per weight basis) (Chen and Mitra 2008; 
Wang et al. 2011).
The CPPs purchased low-endotoxin 
bovine serum albumin (BSA) from Gemini 
Bio-Products (West Sacramento, CA); 
dipalmitoylphosphatidylcholine, phorbol 
12-myristate, 13-acetate (PMA), and lipo-
polysaccharide (LPS from Escherichia coli 
0127:B8) from Sigma-Aldrich (St. Louis, 
MO); and 1,25-dihydroxy-vitamin D3 from 
EMD Millipore (Billerica, MA). The CPPs 
purchased the cytotoxicity assays CellTiter 
96 (MTS assay) and CytoTox 96 [LDH (lac-
tate dehydrogenase) assay] from Promega 
(Madison, WI).
Preparation of ENMs in cell culture 
media. The CPPs prepared ENM stock solu-
tions (5 mg/mL) from dry powder using 
endotoxin-free sterile water and then prepared 
all ENM suspensions in cell culture media 
using the stock solutions as needed. Briefly, 
the CPPs vortexed and then sonicated 
ENM stock solutions (with the exception 
of TiO2-NB, which was stirred to prevent 
mechanical shear) using a water bath sonicator 
or cup horn sonicator (depending on labora-
tory availability) immediately before diluting 
the solutions into complete cell culture media.
Cell culture and co-incubation with EMN. 
The CPPs grew all cells at 37°C in a 5% CO2 
atmosphere. RLE-6TN cells, a rat alveolar 
type II epithelial cell line, from American 
Type Culture Collection (ATCC; Manassas, 
VA) were cultured in Ham’s F12 medium 
(ATCC) supplemented with l-glutamine, 
bovine pituitary extract (BPE), insulin, insulin 
growth factor (IGF)-1, transferrin, and epithe-
lial growth factor (EGF), supplemented with 
10% fetal bovine serum (FBS). THP-1 cells, 
a human acute monocytic leukemia cell line 
(ATCC) were cultured in HEPES-buffered 
RPMI 1640 supplemented with l-gluta-
mine (Mediatech, Corning, NY), 0.05 mM 
b-mercapto ethanol, and 10% FBS (PAA 
Laboratories, Dartmouth, MA). BEAS-2B 
cells (ATCC) were cultured in bronchial epi-
thelial growth medium (BEGM) obtained 
from Lonza Inc. (Walkersville, MD) supple-
mented with BPE, insulin, hydrocortisone, 
human EGF, epinephrine, triiodothyronine, 
transferrin, gentamicin/amphotericin-B, and 
retinoic acid. For the THP-1 differentiation 
performed in the first series of experiments 
(phase I), the CPPs pretreated cells with 
1.62 µM (1 µg/mL) PMA for 18 hr. However, 
the CPPs identified excessive cell clumping 
and cell death during the phase I studies. 
Therefore, the CPPs alternatively pretreated 
THP-1 cells with vitamin D3 at 150 nM 
overnight and then 5 nM PMA in order to 
obtain the differentiated macrophage-like cells 
used during the second series of experiments 
(phase II). For the IL-1β release, co-culturing 
THP-1 cells with 10 ng/mL LPS was neces-
sary to initiate transcription of pro-IL-1β. The 
CPPs initiated aggressive phagocytic activity 
by adding PMA just before particle exposure.
Before ENM exposure, the CPPs cul-
tured aliquots of 1.5 × 104 cells (for THP-1 
cells, 105 cells were seeded into each well of 
a 96-well plate) in 0.2 mL of the cell culture 
media in 96-well plates (Costar, Corning, NY) 
at 37°C for 24 hr. The CPPs freshly prepared 
all of the ENM suspensions at final concentra-
tions of 10, 25, 50, and 100 µg/mL in the 
cell culture media. After exposure of the cells 
to the ENMs for 24 hr at 37°C, the CPPs 
collected supernatants to measure LDH and 
IL-1β production then used the remaining 
cells to test cellular viability by MTS assay.
Physicochemical characterization of 
ENMs. The CPPs identified the primary 
particle size and morphology of the ENMs 
by using a transmission electron microscope 
(TEM; model 100CX) and a scanning elec-
tron microscope (SEM; model JSM-7600F) 
(both from JEOL Ltd., Tokyo, Japan). In 
addition, the CPPs characterized the particle 
hydrodynamic size in H2O and cell culture 
media using dynamic light scattering (DLS) 
(Ji et al. 2010). The CPPs characterized par-
ticle crystallinity and structure using X-ray 
diffraction measurements and measured 
particle surface area by Brunauer–Emmett–
Teller (BET) surface area analysis. The CPPs 
performed zeta-potential measurements of 
the ENM suspensions using a ZetaSizer 
Nano-ZS instrument (Malvern Instruments, 
Worcestershire WR, UK). Finally, the CPPs 
determined the elemental composition of the 
particles as well as ZnO dissolution rate using 
inductively coupled plasma mass spectrom-
etry (ICP-MS) (model SCIEX Elan DRCII; 
PerkinElmer, Norwalk, CT).
Endotoxin analysis of ENMs. CPPs mea-
sured the endotoxin content of ENM stock 
suspensions, as well as dispersions in PBS and 
tissue culture media, using the colorimetric 
Limulus amebocyte lysate assay (Lonza Inc.). 
The LPS content of all ENM suspensions 
was < 0.3 EU/mL.
Determination of cell viability. The CPPs 
determined cellular viability using MTS 
(CellTiter 96) and LDH (CytoTox 96; both 
from Promega) according to the manufac-
turer’s protocols. To avoid the interference 
created by ENMs while measuring formazan 
absorbance at 490 nm, the CPPs introduced 
a centrifugation (2000 × g for 10 min) proce-
dure in phase II experiments to collect particles 
in the wells after incubation with the MTS 
reagents. CPPs then followed this centrifuga-
tion step with a brief mixing and transfer of the 
supernatant to a new 96-well plate before mea-
suring the formazan absorbance at 490 nm. 
The CPPs eliminated interference of any resid-
ual LDH in FBS by heat- inactivation (70°C 
water bath for 5 min).
ELISA for IL-1β quantification. The CPPs 
determined IL-1β production in the THP-1 
culture supernatant using a human IL-1β 
ELISA kit (R&D Systems Human IL-1β 
DuoSet™; R&D Systems, Minneapolis, MN) 
following the manufacturer’s instructions.
Statistical analysis. The CPPs used the two-
way analysis of variance followed by Tukey or 
Bonferroni correction for multiple compari-
sons of means for statistical analysis of responses 
across ENMs and cell lines. In order to define 
inter laboratory comparisons across two har-
monization rounds, the CPPs conducted a 
meta-analysis of LDH, MTS, and IL-1β assays 
across eight different laboratories for three 
cell lines (BEAS-2B, RLE-6TN, and THP-1) 
exposed to several ENMs (TiO2-P25, TiO2-A, 
TiO2-NBs, ZnO, O-MWCNT, P-MWCNT, 
and F-MWCNT). The CPPs combined 
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information within assays and cell lines using 
a robust two-stage hierarchical model of tox-
icity. For all quantities of interest, the CPPs 
obtained Monte Carlo inference by implement-
ing a custom Gibbs sampler in the R comput-
ing environment (R Foundation for Statistical 
Computing, Vienna, Austria). To normalize 
data, the CPPs subtracted background negative 
control values (MTS, LDH, and IL-1β) and 
provided adjustments for positive control values 
in the case of LDH assays. Details about the 
statistical model used for analysis are provided 
in Supplemental Material, p. 8 (http://dx.doi.
org/10.1289/ehp.1306561).
Results
Physicochemical characterization of con-
sortium ENMs. The consortium selected 
two types of nanomaterials for the studies 
in order to evaluate a sufficient number of 
material types: a) metal oxides (TiO2-P25, 
TiO2-A, TiO2-NBs, and ZnO), and b) three 
multiwall carbon nanotubes (O-MWCNT, 
P-MWCNT, and F-MWCNT). A key ele-
ment of this study was that all of the inves-
tigators used the same sets of ENMs, which 
had been extensively characterized a priori. 
Representative SEM images show the mor-
phology of the different ENMs: TiO2-P25, 
TiO2-A, and ZnO were spherical; TiO2-NBs 
were straight, long fibers; O-MWCNT, 
P-MWCNT, and F-MWCNT were long fibers 
(Figure 1). The CPPs additionally characterized 
the ENMs to determine size, surface area, crys-
tal structure, and purity (Tables 1 and 2). To 
determine the hydrodynamic size and charge 
of these materials, the CPPs used both water 
and cell culture media, respectively [in water, 
Tables 1 and 2; for in media, see Supplemental 
Material, Tables S1 and S2 (http://dx.doi.
org/10.1289/ehp.1306561)]. Functionalization 
of MWCNT increased the negative surface 
charge in water, as expected. It should be noted 
Figure 1. SEM images of ENMs: (A) TiO2-P25, (B) TiO2-NB, (C) TiO2-A, (D) ZnO, (E) O-MWCNT, (F) P-MWCNT, and (G) F-MWCNT.
TiO2 -P25 TiO2 -NB TiO2 -A ZnO
F-MWCNTP-MWCNTO-MWCNT
Table 1. Physicochemical characterization of TiO2 and ZnO ENMs.
Quality Technique TiO2-P25 TiO2-A TiO2-NBs ZnO
Size (nm) TEM ~ 24 ~ 28 L:7000; W:200; T:10 ~ 20
Size in H2O (intensity-based) (nm ± SD) DLS 209 ± 8 (PdI 0.065) 292 ± 70 2,897 ± 117 215 ± 15 (PdI 0.033)
Phase and structure XRD 81% anatase and 19% rutile 100% anatase 100% anatase 100% zincite
Shape/morphology TEM Spheroid Spherical Belt Spheroid
Surface area (m2/g) BET 53 173 18 26
Zeta potential in H2O at pH 6.0 (mV ± SD) Zetasizer –34.4 ± 1.6 –30.7 ± 0.8 –30.3 ± 2.8 –28.2 ± 0.5
Elemental analysis (weight percent) ICP-MS 98.6 NA NA 99.3
Abbreviations: L, length; NA, not available; PdI, polydispersity index; T, thickness; W, width; XRD, X-ray defraction.
Table 2. Physicochemical characterization of MWCNTs.
Quality Technique O-MWCNT P-MWCNT F-MWCNT
Size (nm) TEM D: 20–30; L: 5,000–10,000 D: 20–30; L: 5,000–10,000 D: 20–30; L: 5,000–10,000
Size in H2O (intensity-based) (nm ± SD) DLS 324 ± 33 858 ± 58 234 ± 24
Shape/morphology TEM Nanotube Nanotube Nanotube
Surface area (m2/g) BET 180 513 26
Zeta potential in H2O at pH 6.0 (mV ± SD) Zetasizer –12.1 ± 0.3 –11.8 ± 1.1 –48.4 ± 1.7
Elemental analysis (weight percent) ICP-MS 4.5% Ni, 0.8% Fe 1.8% Ni, 0.1% Fe 0.2% S
Abbreviations: D, diameter; Fe, iron; L, length; Ni, nickel, S, sulfur.
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that hydro dynamic diameters for non spherical 
particles such as nanotubes and nanowires are 
defined as the equivalent spherical diameters 
(i.e., the diameter of a sphere with the same 
translational diffusion coefficient) and cannot 
be simply related to the exact particle sizes. 
Therefore, the hydrodynamic diameters mea-
sured here for TiO2-NBs and MWCNTs only 
represent their “relative” sizes. DLS measure-
ments provide a good indication of the disper-
sion state of high-aspect-ratio ENMs such as 
MWCNTs (Wang et al. 2010) and cerium 
oxide (CeO2) nanorods and nanowires (Ji 
et al. 2012). For MWCNTs, the CPPs per-
formed additional experiments using BEGM 
medium (for BEAS-2B cells), showing that the 
combination of BSA and 1,2-dipalmitoyl-sn-
glycero-3 phosphocholine (DPPC) provided 
optimal suspension stability (see Supplemental 
Material, Figure S1A). In addition, because 
ZnO has been shown to dissolve in aqueous 
solutions, the CPPs determined the dissolution 
rate of ZnO in water and BEGM and DMEM 
media. At 24 hr, the percentage of dissolution 
was 12%, 32%, and 35%, respectively (see 
Supplemental Material, Figure S1B). Detailed 
protocols and extra supplementary raw data 
are available online [Center for Environmental 
Health Sciences (CEHS) 2012].
Cytotoxicity of ENMs. In vitro studies 
with ENMs involved eight laboratories and 
included two phases. In some cases not all eight 
laboratories were able to report full results. For 
instance, some optical density readings were 
> 2.0, and some laboratories had 100% cell 
lysis values lower than the particle-exposed 
values. These data were not usable and were not 
included in the final results. The CPPs carried 
out phase I studies with previously established 
proto cols used in the respective laboratories 
of the consortium members. In contrast, the 
CPPs conducted phase II studies using proto-
cols developed after identifying and solving 
technical problems in phase I. The CPPs 
selected MTS and LDH assays because they 
are the most commonly used single end point 
cell viability assays for nanotoxicity studies in 
the literature (Smith et al. 2011; Wang et al. 
2010; Xia et al. 2008a). The relative simplicity 
of the assay procedures allowed the studies to be 
conducted concurrently.
MTS assays. The CPPs discovered sub-
stantial variations among the replicates within 
individual laboratories in the phase I MTS 
assays using BEAS-2B and RLE-6TN cells. 
Figure 2A shows the low consistency for ZnO 
MTS data using RLE-6TN cells in phase I 
experiments. The CPPs determined that 
ENMs interfered directly with the optical den-
sity readings (Figure 2B, left). Therefore, the 
CPPs eliminated the optical interference by 
adding a centrifugation procedure to isolate 
the suspended ENM at the bottom of the cell 
culture dish, then transferring the supernatants 
to a fresh plate to conduct the absorbance read-
ings (Figure 2B, right). Figure 2C shows the 
phase II results of MTS assay in RLE-6TN 
cells using the updated protocols, and the 
results demonstrated high consistency with low 
variability among different laboratories.
Figure 2D,E shows the combined data 
for the MTS assays using THP-1 cells. When 
comparing the ENMs within each group, the 
CPPs determined that ZnO was the most 
toxic followed by TiO2-NB. None of the 
other ENMs caused any significant toxicity 
as detected by the MTS assay. The combined 
MTS data for the BEAS-2B and RLE-6TN 
cells from all laboratories also showed clear 
toxicity trends for ZnO [see Supplemental 
Material, Figures S2A,C and S3A,C (http://
dx.doi.org/10.1289/ehp.1306561)].
Figure 2F compares reproducibility of 
MTS assays between phases I and II. Stratifying 
by ENM and cell line, the CPPs found that 
both error in mean and measurement error 
were either reduced or left unchanged when 
comparing phase I with phase II data. Overall, 
estimations show a 30% (95% CI: 5, 51%) 
reduction in the error in mean between phase I 
and phase II, with significant improvement in 
reproducibility among laboratories. In addi-
tion, a 40% (95% CI: 13, 60%) reduction in 
measurement error occurred between phase I 
and phase II, showing substantially improved 
within-laboratory repeatability.
Figure 2. Phase I/II comparisons for RLE-6TN and THP-1 cells using MTS assay data. (A) Percent viable RLE-6TN cells relative to no-particle control for each 
individual laboratory in phase I. (B) The ENM distorted OD readings in the MTS assay: with the ENM in the culture well (left); with the media supernatant removed 
and replaced in wells without particle interference (right); OD, optical density. (C) Percent viable RLE-6TN cells relative to no-particle control for each individual 
laboratory in phase II. (D,E) Percent viable cells relative to no-particle control for THP-1 phase I conditions (D) and for THP-1 phase II conditions (E). (F) Changes 
in error of the mean (left) and measure in error (right) from phase I to phase II trials for MTS assay data. Data are expressed as mean ± SE.
*p < 0.05 compared with other particles at the same concentration and/or the “no-particle” control.
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LDH assays. Similar to the MTS assays, 
the LDH assay results in response to ZnO 
treatment of RLE-6TN cells improved in 
the second phase of testing. Three laborato-
ries showed high baseline levels in LDH in 
phase I as compared with other laboratories 
and did not have the same dose– response pat-
terns exhibited by the majority of the labora-
tories (Figure 3A). In contrast, the procedural 
improvements in phase II show a much better 
agreement between laboratories (Figure 3B). 
The combined data for the LDH assays 
using THP-1 cells showed the same patterns 
of toxicity compared with the MTS assays 
(Figure 3C,D). The only two ENMs that 
achieved significant toxicity using the LDH 
assay were TiO2-NB and ZnO. Detailed sum-
mary LDH data for BEAS-2B and RLE-6TN 
cells can be found in Supplemental Material, 
Figures S2B,D and S3B,D (http://dx.doi.
org/10.1289/ehp.1306561).
Figure 3E reports the results comparing 
the reproducibility of LDH assays between 
phases I and II. Stratifying by ENM and cell 
line, the CPPs found that both error in mean 
and measurement error were either reduced 
or left unchanged when comparing phase II 
with phase I data. Only one ENM by cell line 
combination (ZnO–RLE-6TN) exhibited 
decreased reproducibility on average, but the 
difference in errors was not statistically signifi-
cant. Comparatively, for the same particle by 
cell line combination, estimations of measure-
ment error showed a substantial reduction 
(40% decrease). Overall, assessments of the 
improvement in assay performance showed 
a 13% (95% CI: –0.12, 42%) improve-
ment in reproducibility and 21% (95% CI: 
–0.09, 53%) improvement in repeatability.
Inflammatory potential of ENMs. The 
above studies demonstrated that only ZnO (all 
models tested) and TiO2-NB (THP-1 only) 
caused in vitro cytotoxicity. Because cyto-
toxicity does not necessarily translate mecha-
nistically to in vivo pathology, the consortium 
studies included measurement of NLRP3 
inflammasome generated IL-1β from THP-1 
cells. The results of the phase I experi ments 
measuring IL-1β production using THP-1 
cells demonstrated that only two labora tories 
showed a significant increase from TiO2-NB 
treatment (Figure 4A). The CPPs determined 
that the interlaboratory inconsistency in the 
phase I experimental results was possibly 
due to cell clumping and excessive cell death 
when using PMA alone for differentiation 
(Figure 4B, left). In order to improve data 
consistency, the CPPs modified the macro-
phage differentiation method by using vita-
min D3 followed by a lower concentration of 
PMA (Figure 4B, right). Figure 4C shows that 
after using the improved protocols in phase II 
studies, all laboratories reported significant 
increases in IL-1β production in THP-1 cells 
in response to TiO2-NB.
Figure 4D,E shows the combined data 
from the phase I and phase II studies, respec-
tively. The large error bars in phase I were 
due to the sizeable between-laboratory varia-
tion shown in Figure 4A. Consequently, 
only TiO2-NB caused a nonsignificant dose-
dependent IL-1β release. In contrast, in 
phase II the combined data demonstrated 
that TiO2-NB caused a significant IL-1β 
release from THP-1 cells and MWCNTs 
also increased IL-1β release, although the 
results did not achieve significance when all 
laboratories were averaged. The between- 
laboratory variance and the large effect of the 
TiO2-NBs negated any significance of the 
MWCNT IL-1β dose-dependent increases 
shown in Figure 4E. However, consideration 
of the individual laboratory data showed a 
significant dose-dependent increase for the 
O-MWCNT in all but two laboratories [see 
Supplemental Material, Figure S4 (http://
dx.doi.org/10.1289/ehp.1306561)]. In 
every case, ranking the bioactivity of the 
MWCNTs resulted in the following order: 
O-MWCNT > P-MWCNT > F-MWCNT. 
The probability of this rank order occur-
ring in every laboratory by chance was 
p < 0.001. In contrast ZnO, which was the 
most cytotoxic of the ENMs, did not cause 
any apparent IL-1β release regardless of dose 
(Figure 4E).
Figure 4F shows the results compar-
ing reproducibility of IL-1β assays between 
phases I and II. Stratifying by ENM, com-
parisons of phase I and phase II data show 
a reduction in both error in mean and mea-
surement error. Combination of all ENMs 
Figure 3. Phase I/II comparisons for RLE-6TN and THP-1 cells using LDH assay data. (A,B) Percent LDH release in RLE-6TN cells relative to total cell lysis (100% 
cell death) for each individual laboratory in phase I (A) and in phase II (B). (C,D) Percent LDH release relative to total lysis for THP-1 phase I conditions (C) and 
for THP-1 phase II conditions (D). (E) Changes in error of the mean (left) and measure in error (right) from phase I to phase II trials for LDH assay data. Data are 
expressed as mean ± SE. 
*p < 0.05 compared with other particles at the same concentration and/or the “no-particle” control.
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and cell lines showed an estimated 74% 
(95% CI: 41, 95%) reduction in the error in 
mean and significant improvement in repro-
ducibility among laboratories. Furthermore, 
within- laboratory repeatability improved sub-
stantially with an 83% (95% CI: 63, 99%) 
reduction in measurement error.
Discussion
The NIEHS consortium conducted this study 
in an effort to identify and minimize sources 
of variability among laboratories perform-
ing in vitro testing of ENMs. Eight laborato-
ries participated in all or part of two rounds 
(phase I and phase II) of in vitro tests using 
cell lines and ENM types that were collec-
tively selected by consortium members. After 
identification of several technical problems 
in phase I, the CPPs significantly improved 
the interlaboratory variability in phase II. 
Furthermore, conclusions on the relative 
potency of the different ENMs for both tox-
icity and bioactivity will contribute to the 
information necessary to help predict rela-
tive risk for the ENMs. In addition, results 
showed the MTS assay to be comparable in 
data quality and predictive value when com-
pared with the LDH assay for toxicity testing.
A significant finding of this study was that 
the development of harmonized in vitro assay 
protocols made it possible to achieve repro-
ducible results among different laboratories. 
This study was among the first attempts of 
large scale round-robin tests of ENMs at the 
national and international level. There have 
been reports of a successful effort to perform 
interlaboratory comparisons to characterize 
ENMs by establishing detailed shipping, mea-
surement, and reporting protocols (Lamberty 
et al. 2011; Roebben et al. 2011). Specifically, 
researchers demonstrated a reduction in inter-
laboratory variations, especially for dynamic 
scattering measurements (Roebben et al. 
2011). In comparison, the present study out-
lined a novel method of in vitro testing using 
multiple cell types, ENMs, and assays.
The planning of these in vitro tests 
included steps to control for many factors. For 
example, protocol development included con-
sideration of varying cell culture conditions, 
cell type, cell number, and cell viability, assay 
protocols, and most important, experience 
of the scientist that actually performed the 
experiments. To this end, the CPPs obtained 
cells and reagents from the same batch or 
lot number and followed a detailed cell cul-
ture and assay protocol for each experiment. 
Investigators and laboratory personnel estab-
lished a mechanism to communicate with oth-
ers and to share their experience in performing 
specific assays. The frequent communication 
was very helpful for achieving reproducible 
results within and among the laboratories.
The strategies established for inter-
laboratory communication provided a founda-
tion for developing more effective protocols 
during phase II studies to account for the 
inherent difficulties in evaluating ENMs. 
For example, through close communication, 
the CPPs determined that ENMs interfere 
with optical density readings—creating arti-
facts and erroneous high MTS values (Kroll 
et al. 2012). The phase I MTS assay proto-
col, as based on the Promega manufacturer’s 
instructions, did not take into consideration 
potential absorbance anomalies created by the 
ENMs. As a result, although the combined 
phase I MTS assays showed clear toxicity pro-
files of TiO2-P25, TiO2-A, TiO2-NB, and 
ZnO in RLE-6TN and BEAS-2B cells [see 
Supplemental Material, Figures S2 and S3 
(http://dx.doi.org/10.1289/ehp.1306561)], 
a large variation existed among the laborato-
ries, as shown in Figure 2A. The CPPs deter-
mined this anomaly to be due to the presence 
of residual ENM following treatment of the 
cells, as demonstrated in Figure 2B. Therefore, 
the phase II protocol introduced a simple cen-
trifugation step and media removal after MTS 
reagent incubation, thus allowing the absor-
bance to be read using supernatant containing 
ENM-free MTS solution. This additional step 
eliminated the ENM interference with the 
assay and significantly improved the intra- and 
interlaboratory consistency.
The CPPs determined ENM interference 
to be only one potential source of variability 
for in vitro assays. Phase I results of the LDH 
and IL-1β assays clearly demonstrated that 
cell culture conditions also contributed to 
the observed variability. Stimulated release 
of IL-1β from THP-1 cells relied in part on 
Figure 4. Phase I/II comparisons for THP-1 cells using IL-1β assay data. (A) Percent IL-1β release from THP-1 cells for each individual laboratory in phase I. 
(B) THP-1 cell differentiation technique altered cell morphology: THP-1 cells pretreated with 1.62 µM PMA for 24 hr formed clumps (left), whereas cells pretreated 
with vitamin D3 overnight and then treated with 5 nM PMA were evenly dispersed (right). (C) IL-1β release from THP-1 cells for each individual laboratory in 
phase II. (D,E) Summary IL-1β release for phase I conditions (D) and for phase II conditions (E). (F) Changes in error of the mean (left) and measure in error (right) 
from phase I to phase II trials for IL-1β assay data. Data are expressed as mean ± SE.
*p < 0.05 compared with other particles at the same concentration and/or the “no-particle” control. #p < 0.001 for dose response (each laboratory’s data analyzed independently).
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the activation and differentiation of THP-1 
cells by high levels of PMA in the phase I 
protocol. PMA induced strong responses 
in THP-1 cells, resulting in severe clump- 
ing of the THP-1 cells during the activation 
process, in addition to excessive cell death 
occurring upon scraping the cells. Using this 
protocol, only two laboratories demonstrated 
toxicity of TiO2-NBs in the MTS and LDH 
assays or inflammasome activation in the 
IL-1β assay in the phase I tests. However, by 
replacing some of the PMA with vitamin D3, 
a milder signal for THP-1 activation, the 
cells remained well dispersed. Consequently, 
phase II results demonstrated similar results 
for IL-1β production by THP-1 cells stimu- 
lated with TiO2-NBs between laboratories. 
Consortium efforts found that the MTS 
assay was at least equal in reliability to assess 
ENM toxicity as the LDH assay. Both tox- 
icity assays tracked each other very well for 
the different ENMs and cell types. Although 
this finding needs further validation, it sug- 
gests that the easy-to-conduct MTS assay could 
serve as a highly reliable testing method for 
in vitro studies of ENM-induced cytotoxicity 
when conducted as described in the phase II 
protocol. Supplemental information is avail- 
able online (CEHS 2012). The observation of 
a difference in the relative potency between 
TiO2-NB and ZnO between the two assays 
is likely not as important as the observation 
that both were significantly cytotoxic in vitro, 
suggesting that both ENMs should be tested 
in vivo. 
The consortium studies also provided 
reproducible findings of relative toxicity and 
bioactivity of the various ENMs across the 
different cell lines. For example, ZnO was 
highly toxic to all three cell types examined 
in this study, yet it did not stimulate inflam- 
masome activity in THP-1 cells (Figure 4), 
suggesting that cytotoxicity and bioactivity 
(e.g., stimulation of inflammasome-mediated 
IL-1β release) do not necessarily correlate. 
Studies on inflammation and lung pathology 
implicate the importance of inflammasome- 
generated IL-1β production (Cassel et al. 
2008; Dostert et al. 2008; Franchi et al. 2009; 
Tschopp and Schroder 2010). In addition, a 
consortium laboratory recently demonstrated 
the importance of IL-1β release in generat- 
ing an inflammatory response to MWCNTs 
in vivo (Girtsman et al. 2012). Therefore, 
the consortium recommends the inclusion 
of mechanism-linked bioactivity assays along 
with traditional cytotoxicity assays for in vitro 
ENM screening. 
The two forms of TiO2 nanospheres (P25 
and A) were not significantly cytotoxic or 
bioactive, yet TiO2-NBs were highly cyto- 
toxic and selectively induced inflammasome 
activity toward THP-1 cells, consistent with 
previous studies (Hamilton et al. 2009). The 
lack of toxicity of the TiO2-NBs toward epi- 
thelial cells can probably be explained by their 
poor internalization of the material, and sug- 
gests that if in vitro studies were conducted 
solely with epithelial cell lines such as those 
used in this study, the high toxicity of this 
material would not have been identified. 
Consequently, an important recommendation 
is to conduct studies with multiple relevant 
cell types to avoid false-negative outcomes. 
In parallel with the in vitro studies, another 
consortium effort among seven different labo- 
ratories conducted in vivo studies using rats, 
mice, and most of the ENMs described in the 
present study. These researchers performed 
similar efforts to address technical issues and 
methods to reduce variability (Bonner et al. 
2013). The CPPs in vitro TiO2 studies pre- 
dicted the in vivo outcomes with more labora- 
tories observing significant lung inflammation 
with the TiO2-NBs compared with the two 
nanosphere forms. The results presented in 
this study are also consistent with a recent 
report demonstrating that TiO2-NBs, but not 
nanospheres, caused lung fibrosis (Porter et al. 
2013). Furthermore, observations showed a 
greater activity of O-MWCNT compared 
with P-MWCNT or F-MWCNT. Therefore, 
the in vitro studies had the potential to accu- 
rately predict the relative potency for the 
TiO2 materials observed in vivo. In fact, the 
IL-1β (proxy measure for NLRP3 inflamma- 
some) result from this study would predict 
that the TiO2-NBs and the O-MWCNT 
would be the two ENMs that would result 
in the greatest inflammation, and that was 
confirmed in the corresponding in vivo work 
(Bonner et al. 2013). 
Conclusions 
These studies strove to improve concordance 
of test results among laboratories while ensur- 
ing that the assays were predictive of in vivo 
outcome. The CPPs achieved the goal of pro- 
ducing reliable and repeatable in vitro toxicity 
testing for ENMs; however, improving the 
predictability of the assays is still a work in 
progress. Care needs to be taken to understand 
the limitation of in vitro testing and not to 
overinterpret in vitro studies without com- 
prehensive companion in vivo studies. These 
studies used well-characterized nanomaterials, 
including a positive and negative control, in 
addition to a well-established dispersion pro- 
tocol ensuring stable suspensions in cell cul- 
ture media. This consortium effort provided 
a series of harmonized protocols and tested 
models for the nanotoxicological field to use. 
The results also demonstrated that toxicity and 
inflammasome activity did not always track 
each other and that different cell types yielded 
different estimates of safety of different ENMs. 
Consequently, future studies should utilize 
multiple end points and multiple cell types to 
avoid false-negative results. Finally, this effort 
serves as a good template for future endeav- 
ors in the field of nanotoxicology, providing 
key elements necessary for collaborative efforts 
between laboratories. 
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